Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

2.

Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.

Uwagawa T, Yanaga K.

Surg Today. 2015 Dec;45(12):1481-8. doi: 10.1007/s00595-015-1129-z. Epub 2015 Feb 12. Review.

PMID:
25673034
3.

Therapeutic applications of curcumin for patients with pancreatic cancer.

Kanai M.

World J Gastroenterol. 2014 Jul 28;20(28):9384-91. doi: 10.3748/wjg.v20.i28.9384. Review.

4.

Curcumin in combined cancer therapy.

Troselj KG, Kujundzic RN.

Curr Pharm Des. 2014;20(42):6682-96. Review.

PMID:
25341940
5.

Novel therapies for pancreatic adenocarcinoma.

Pino SM, Xiong HQ, McConkey D, Abbruzzese JL.

Curr Gastroenterol Rep. 2004 Apr;6(2):119-25. Review.

PMID:
15191689
6.

Salirasib in the treatment of pancreatic cancer.

Bustinza-Linares E, Kurzrock R, Tsimberidou AM.

Future Oncol. 2010 Jun;6(6):885-91. doi: 10.2217/fon.10.71. Review.

PMID:
20528225
7.

Novel therapies for pancreatic adenocarcinoma.

Pino SM, Xiong HQ, McConkey D, Abbruzzese JL.

Curr Oncol Rep. 2004 May;6(3):199-206. Review.

PMID:
15066231
8.

NF-kappa B: a new player in angiostatic therapy.

Tabruyn SP, Griffioen AW.

Angiogenesis. 2008;11(1):101-6. doi: 10.1007/s10456-008-9094-4. Epub 2008 Feb 19. Review.

9.

Chemoprevention strategies for pancreatic cancer.

Stan SD, Singh SV, Brand RE.

Nat Rev Gastroenterol Hepatol. 2010 Jun;7(6):347-56. doi: 10.1038/nrgastro.2010.61. Epub 2010 May 4. Review.

10.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Wilken R, Veena MS, Wang MB, Srivatsan ES.

Mol Cancer. 2011 Feb 7;10:12. doi: 10.1186/1476-4598-10-12. Review.

11.

Potential anticancer properties and mechanisms of action of curcumin.

Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C.

Anticancer Res. 2015 Feb;35(2):645-51. Review.

PMID:
25667441
12.

NF-kappaB and cancer: how intimate is this relationship.

Prasad S, Ravindran J, Aggarwal BB.

Mol Cell Biochem. 2010 Mar;336(1-2):25-37. doi: 10.1007/s11010-009-0267-2. Epub 2009 Oct 8. Review.

13.

Curcumin and lung cancer--a review.

Mehta HJ, Patel V, Sadikot RT.

Target Oncol. 2014 Dec;9(4):295-310. doi: 10.1007/s11523-014-0321-1. Epub 2014 May 21. Review.

PMID:
24840628
14.

NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.

Sebens S, Arlt A, Schäfer H.

Recent Results Cancer Res. 2008;177:151-64. Review.

PMID:
18084957
15.

Targeting NF-kappaB for colorectal cancer.

Sakamoto K, Maeda S.

Expert Opin Ther Targets. 2010 Jun;14(6):593-601. doi: 10.1517/14728221003769903. Review.

PMID:
20367537
16.

Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.

Mimeault M, Brand RE, Sasson AA, Batra SK.

Pancreas. 2005 Nov;31(4):301-16. Review.

PMID:
16258363
17.

Antitumor, anti-invasion, and antimetastatic effects of curcumin.

Kuttan G, Kumar KB, Guruvayoorappan C, Kuttan R.

Adv Exp Med Biol. 2007;595:173-84. Review.

PMID:
17569210
18.

Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway.

Panahi Y, Darvishi B, Ghanei M, Jowzi N, Beiraghdar F, Varnamkhasti BS.

Cytokine Growth Factor Rev. 2016 Apr;28:21-9. doi: 10.1016/j.cytogfr.2015.12.004. Epub 2016 Jan 2. Review.

PMID:
26774676
19.

Molecular mechanisms of curcumin action: gene expression.

Shishodia S.

Biofactors. 2013 Jan-Feb;39(1):37-55. doi: 10.1002/biof.1041. Epub 2012 Sep 20. Review.

PMID:
22996381
20.

Molecular targets of curcumin.

Lin JK.

Adv Exp Med Biol. 2007;595:227-43. Review.

PMID:
17569214

Supplemental Content

Support Center